HealthAratus Intelligence

Transpara

Screenpoint Medical
Transpara Intelligence Room

Transpara Intelligence

What the accumulated evidence, deployment record and lived experience actually show.

Intelligence lenses

Four ways of interrogating the same reality. Each changes the question, not the subject.

Do published findings about Transpara match what happens in practice?

  • Public evidence

    The Lancet publishes final results from the first randomized controlled trial in Breast AI

    SignalHunt:validation:ScreenPoint

  • Public evidence

    ScreenPoint Medical's Transpara AI Selected for Landmark $16M Breast Cancer Screening Trial

    SignalHunt:validation:ScreenPoint

  • Public evidence

    ScreenPoint Medical Raises $16M for AI Breast Cancer Detection

    SignalHunt:validation:ScreenPoint

  • Public evidence

    ScreenPoint Medical Showcases Global Momentum for Transpara(R) Breast AI at EUSOBI

    SignalHunt:validation:ScreenPoint

What we know · what we don’t

Everything here is open to being corrected by someone who has seen it first-hand.

What we still don’t know

Nobody has answered these yet. Your experience can help us understand what is happening.

Unresolved

We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.

Not yet answered

What are we missing?

Matters of record

Settled elsewhere. Context for reading the above, not something practice can confirm.

  • 4 public external signal(s) across 1 source(s).Recorded by HealthAratus

Tool intelligence

What HealthAratus understands

HealthAratus currently understands Transpara through company records and external market activity.

Category
imaging_diagnostics

What HealthAratus is still learning

HealthAratus is beginning to understand Transpara. As evidence and experience accumulate, what remains unclear will be stated here.

Evidence & claims

What this is built on

The material the questions above were built from, with its attribution.

Transpara is an artificial intelligence software for mammography. It assists radiologists by analyzing breast imaging exams.According to Screenpoint Medical

What Screenpoint Medical states

The vendor’s own claims. Testable where practice can actually test them.

Stated capability

The system provides an automated assessment score for each mammogram.

According to Screenpoint Medical

Does this change your workflow?

Independent and public evidence

Found in public sources. Not a clinician’s experience, and never presented as one.

Reported deployment

ScreenPoint Medical Showcases Global Momentum for Transpara(R) Breast AI at EUSOBI

Reported publicly

How widely is this actually used?

Reported outcome

The Lancet publishes final results from the first randomized controlled trial in Breast AI

Reported publicly

Are you seeing this result?

Reported outcome

ScreenPoint Medical's Transpara AI Selected for Landmark $16M Breast Cancer Screening Trial

Reported publicly

Are you seeing this result?

Recent change

ScreenPoint Medical Raises $16M for AI Breast Cancer Detection

Reported publicly

Have you noticed this shift?

Company participation

Not yet verified

A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.

Claim your company profile

Reference

The stable facts, for interpreting everything above.

Overview

What it does

Radiology and imaging AI

Vendor & external product information, not independently verified by HealthAratus

Where it's used

Deployed in mixed settings

Parent Company
Screenpoint Medicalvendor
1 tracked tool

How the reality here has changed

Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Transpara accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.

Connected intelligence